{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2010"],"condition":["Gastric and Colorectal Cancer"],"disease":["Gastric And Colorectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2619585"],"location":["Japan"],"study_start_month":["10"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"A Clinical study to which Anti-emetic effect of change of 5-HT3RA is evaluated by using MAT in MEC for  gastrointestinal cancer.","description":"Interventions: The aloxi 0.75mg is administered before the anti-cancer drug of day1 is administered.\nPrimary outcome(s): The level of each observation point of the nausea and vomiting before and after 5- HT3RA change is evaluated by MAT.\nStudy Design: Single arm Non-randomized","dates":{"creation":"2010-10-15"},"accession":"2619585","cross_references":{"Japan Primary Registries Network":["JPRN-UMIN000004133"]}}